140 related articles for article (PubMed ID: 9043033)
1. Leukaemias and cancers following iodine-131 administration for thyroid cancer.
de Vathaire F; Schlumberger M; Delisle MJ; Francese C; Challeton C; de la Genardiére E; Meunier F; Parmentier C; Hill C; Sancho-Garnier H
Br J Cancer; 1997; 75(5):734-9. PubMed ID: 9043033
[TBL] [Abstract][Full Text] [Related]
2. Second primary malignancies in thyroid cancer patients.
Rubino C; de Vathaire F; Dottorini ME; Hall P; Schvartz C; Couette JE; Dondon MG; Abbas MT; Langlois C; Schlumberger M
Br J Cancer; 2003 Nov; 89(9):1638-44. PubMed ID: 14583762
[TBL] [Abstract][Full Text] [Related]
3. Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.
Glanzmann C
Strahlenther Onkol; 1992 Jun; 168(6):337-43. PubMed ID: 1621212
[TBL] [Abstract][Full Text] [Related]
4. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
6. Leukaemia incidence after iodine-131 exposure.
Hall P; Boice JD; Berg G; Bjelkengren G; Ericsson UB; Hallquist A; Lidberg M; Lundell G; Mattsson A; Tennvall J
Lancet; 1992 Jul; 340(8810):1-4. PubMed ID: 1351599
[TBL] [Abstract][Full Text] [Related]
7. Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients.
Hall P; Holm LE; Lundell G; Rudén BI
Acta Oncol; 1992; 31(4):403-7. PubMed ID: 1632973
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer after diagnostic administration of iodine-131.
Hall P; Mattsson A; Boice JD
Radiat Res; 1996 Jan; 145(1):86-92. PubMed ID: 8532842
[TBL] [Abstract][Full Text] [Related]
9. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
11. Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92.
Auvinen A; Hakama M; Arvela H; Hakulinen T; Rahola T; Suomela M; Söderman B; Rytömaa T
BMJ; 1994 Jul; 309(6948):151-4. PubMed ID: 8044092
[TBL] [Abstract][Full Text] [Related]
12. Induction of leukemia by 131-I treatment of thyroid carcinoma.
Brincker H; Hansen HS; Andersen AP
Br J Cancer; 1973 Sep; 28(3):232-7. PubMed ID: 4517840
[TBL] [Abstract][Full Text] [Related]
13. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
[TBL] [Abstract][Full Text] [Related]
14. Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma.
Rubino C; Adjadj E; Doyon F; Shamsaldin A; Abbas TM; Caillou B; Colonna M; Cecarreli C; Schvartz C; Bardet S; Langlois C; Ricard M; Schlumberger M; de Vathaire F
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1084-9. PubMed ID: 15990012
[TBL] [Abstract][Full Text] [Related]
15. Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study.
Seo GH; Kong KA; Kim BS; Kang SY; Moon BS; Yoon HJ; Kim HO
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2580-e2588. PubMed ID: 33755732
[TBL] [Abstract][Full Text] [Related]
16. Risk of thyroid cancer after exposure to 131I in childhood.
Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
[TBL] [Abstract][Full Text] [Related]
17. 131I ablation treatment in young females after the Chernobyl accident.
Travis CC; Stabin MG
J Nucl Med; 2006 Oct; 47(10):1723-7. PubMed ID: 17015910
[TBL] [Abstract][Full Text] [Related]
18. Cancer risks and biomarker studies in the atomic bomb survivors.
Preston D
Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
[TBL] [Abstract][Full Text] [Related]
19. Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management.
Kumagai A; Reiners C; Drozd V; Yamashita S
Endocr J; 2007 Dec; 54(6):839-47. PubMed ID: 17938505
[TBL] [Abstract][Full Text] [Related]
20. Leukemia after 131I treatment of thyroid cancer--comments on the article 'Second cancer following chemotherapy and radiotherapy--an epidemiological perspective' by J. Kaldor.
Advani SH; Hege UP
Acta Oncol; 1992; 31(1):65. PubMed ID: 1586507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
